Metabolic Aspects of Polycystic Ovary Syndrome

Abstract

Dr. Dhesi is Resident, and Dr. Morelli is Assistant Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Rutgers–New Jersey Medical School, 185 S. Orange Ave, MSB E-506, Newark, NJ 07103; E-mail: [email protected]. All faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity. The authors have disclosed that the use of metformin for treatment of polycystic ovary syndrome as discussed in this article has not been approved by the U.S. Food and Drug Administration. Please consult the product labeling for approved uses. Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This activity expires on August 30, 2016.